These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9364949

  • 1. Low density barium and bentonite mixture versus high density barium: a comparative study to optimize negative gastrointestinal contrast agents for MRI.
    Paley MR, Nicolas AI, Mergo PJ, Torres GM, Burton SS, Ros PR.
    Magn Reson Imaging; 1997; 15(9):1033-6. PubMed ID: 9364949
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB, Rappaport DC, Ros PR, Torres GM.
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [Abstract] [Full Text] [Related]

  • 3. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers.
    Ros PR, Steinman RM, Torres GM, Burton SS, Panaccione JL, Rappaport DC, McGorray SP.
    AJR Am J Roentgenol; 1991 Oct; 157(4):761-7. PubMed ID: 1892032
    [Abstract] [Full Text] [Related]

  • 4. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN, Francis IR.
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [Abstract] [Full Text] [Related]

  • 5. Optimization of a negative oral contrast agent for magnetic resonance imaging.
    Davis MA, Mei H, Ritsema GH.
    Invest Radiol; 1994 Jun; 29 Suppl 2():S120-2. PubMed ID: 7928205
    [No Abstract] [Full Text] [Related]

  • 6. Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies.
    Li KC, Tart RP, Fitzsimmons JR, Storm BL, Mao J, Rolfes RJ.
    Magn Reson Imaging; 1991 Jun; 9(2):141-50. PubMed ID: 2034046
    [Abstract] [Full Text] [Related]

  • 7. High-density oral barium sulfate in abdominal MRI: efficacy and tolerance in a clinical setting.
    Burton SS, Liebig T, Frazier SD, Ros PR.
    Magn Reson Imaging; 1997 Jun; 15(2):147-53. PubMed ID: 9106142
    [Abstract] [Full Text] [Related]

  • 8. High density barium sulfate suspension for MRI: optimization of concentration for bowel opacification.
    Ballinger JR, Ros PR.
    Magn Reson Imaging; 1992 Jun; 10(4):637-40. PubMed ID: 1501534
    [Abstract] [Full Text] [Related]

  • 9. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL, Muller HH, Young SW.
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Two Neutral Oral Contrast Agents in Pediatric Patients: A Prospective Randomized Study.
    Dillman JR, Towbin AJ, Imbus R, Young J, Gates E, Trout AT.
    Radiology; 2018 Jul; 288(1):245-251. PubMed ID: 29737955
    [Abstract] [Full Text] [Related]

  • 11. Improved technique for pancreatic MRI: value of oblique fat suppression imaging with oral barium administration.
    Helmberger T, Mergo PJ, Stoupis C, Torres GM, Burton SS, Ros PR.
    J Comput Assist Tomogr; 1998 Jul; 22(3):391-7. PubMed ID: 9606379
    [Abstract] [Full Text] [Related]

  • 12. Oral administration of a low-cost negative contrast agent: a three-year experience in routine practice.
    Ernst O, Sergent G, L'Hermine C.
    J Magn Reson Imaging; 1997 Jul; 7(3):495-8. PubMed ID: 9170033
    [Abstract] [Full Text] [Related]

  • 13. Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging.
    Tomura N, Narita K, Takahashi S, Otani T, Sakuma I, Yasuda K, Nishii T, Watarai J.
    Acta Radiol; 2007 Nov; 48(9):1032-7. PubMed ID: 17957522
    [Abstract] [Full Text] [Related]

  • 14. A potentially artifact-free oral contrast agent for gastrointestinal MRI.
    Liebig T, Stoupis C, Ros PR, Ballinger JR, Briggs RW.
    Magn Reson Med; 1993 Nov; 30(5):646-9. PubMed ID: 8259066
    [Abstract] [Full Text] [Related]

  • 15. An aqueous gastrointestinal contrast agent for use in echo-planar MR imaging.
    Hahn PF, Saini S, Cohen MS, Goldberg M, Reimer P, Mueller PR.
    Magn Reson Med; 1992 Jun; 25(2):380-3. PubMed ID: 1614323
    [Abstract] [Full Text] [Related]

  • 16. High density barium sulphate as an MRI oral contrast.
    Marti-Bonmati L, Vilar J, Paniagua JC, Talens A.
    Magn Reson Imaging; 1991 Jun; 9(2):259-61. PubMed ID: 2034060
    [Abstract] [Full Text] [Related]

  • 17. A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis.
    Small WC, DeSimone-Macchi D, Parker JR, Sukerkar A, Hahn PF, Rubin DL, Zelch JV, Kuhlman JE, Outwater EK, Weinreb JC, Brown JJ, de Lange EE, Woodward PJ, Arildsen R, Foster GS, Runge VM, Aisen AM, Muroff LR, Thoeni RF, Parisky YR, Tanenbaum LN, Totterman S, Herfkens RJ, Knudsen J, Bernardino ME.
    J Magn Reson Imaging; 1999 Jul; 10(1):15-24. PubMed ID: 10398973
    [Abstract] [Full Text] [Related]

  • 18. Intraluminal contrast agents for MR imaging of the abdomen and pelvis.
    Pels Rijcken TH, Davis MA, Ros PR.
    J Magn Reson Imaging; 1994 Jul; 4(3):291-300. PubMed ID: 8061424
    [Abstract] [Full Text] [Related]

  • 19. Gastrointestinal tract labeling for MDCT of abdomen: comparison of low density barium and low density barium in combination with water.
    Gulati K, Shah ZK, Sainani N, Uppot R, Sahani DV.
    Eur Radiol; 2008 May; 18(5):868-73. PubMed ID: 18183403
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms that contribute to the in vitro relaxation and signal intensity of water in barium sulfate suspensions used as MRI contrast agents.
    Briggs RW, Liebig T, Ballinger JR, Ros PR.
    Magn Reson Imaging; 1993 May; 11(5):635-44. PubMed ID: 8345778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.